A commonly used three-drug regimen for idiopathic pulmonary fibrosis has been found harmful.

NIH has stopped one treatment arm of the trial; other two treatments are continuing.
The complete text for the alert is available at: http://www.nlm.nih.gov/databases/alerts/2011_nhlbi_ifp.html  /ch

This entry was posted on Tuesday, October 25th, 2011 at 5:34 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.